Search Results - "Walls, Andrew C"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Penile calciphylaxis: A retrospective case-control study by Gabel, Colleen, Chakrala, Teja, Shah, Radhika, Danesh, Melissa J., Dobry, Allison S., Garza-Mayers, Anna Cristina, Ko, Lauren N., Nguyen, Emily, St. John, Jessica, Walls, Andrew C., Nigwekar, Sagar U., Song, Philip I., Kroshinsky, Daniela

    “…Calciphylaxis is a rare disorder characterized by skin necrosis caused by calcium deposition within vessels, thrombosis, and subsequent tissue ischemia. Penile…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Host Risk Factors, Ultraviolet Index of Residence, and Incident Malignant Melanoma In Situ Among US Women and Men by WALLS, Andrew C, JIALI HAN, LI, Tricia, QURESHI, Abrar A

    Published in American journal of epidemiology (01-05-2013)
    “…The incidences of malignant melanoma in situ (MMIS) and invasive malignant melanoma are rising in the United States, but few studies have examined risk factors…”
    Get full text
    Journal Article
  11. 11

    Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity by Bresler, Scott C, Min, Le, Rodig, Scott J, Walls, Andrew C, Xu, Shuyun, Geng, Songmei, Hodi, F Stephen, Murphy, George F, Lian, Christine G

    Published in Laboratory investigation (01-02-2017)
    “…Ipilimumab (IPI) is a monoclonal antibody that targets the inhibitory CTLA4 receptor of T cells, enhancing T-cell-driven antitumor responses. IPI therapy in…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Impact of the 2009 AJCC staging guidelines for melanoma on the number of mitotic figures reported by dermatopathologists at one institution by Larson, Allison R., Rothschild, Brian, Walls, Andrew C., Granter, Scott R., Qureshi, Abrar A., Murphy, George F., Laga, Alvaro C.

    Published in Journal of cutaneous pathology (01-08-2015)
    “…Background In 2009 the revised seventh staging system for melanoma recommended the use of mitotic count to separate stage T1a from T1b. However, careful…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Update on Cutaneous Small Vessel Vasculitis: Terminology, Morphology, Diagnostic Evaluation, and Management by Reyes-Hadsall, Sophia, Drake, Lara, Walls, Andrew C.

    Published in Current dermatology reports (01-12-2023)
    “…Purpose of the Review Cutaneous small vessel vasculitis (CSVV) is the clinical presentation of the histologic entity of leukocytoclastic vasculitis (LCV); the…”
    Get full text
    Journal Article
  20. 20

    Abstract 5500: Phenotypic risk factors for malignant melanoma in-situ in US women and men by Walls, Andrew C., Li, Tricia, Han, Jiali, Qureshi, Abrar A.

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract Malignant melanoma in-situ (MMIS) has been associated with the risk of invasive melanoma, either through invasive transformation or as a marker for de…”
    Get full text
    Journal Article